Tools & Techniques

Clinical trials suffer from heavy dropout rates. Perhaps the answer is a little care and attention.

Disease research should embrace the biotechnology available to increase drug development success

The war in Ukraine has massively impacted clinical trials. We spoke to one man tracking the disruption.

Could genetic testing put an end to heart disease once and for all?

We sit down with Albert J.R. Heck, Professor at the Science Faculty, Utrecht University, and Scientific Director of the Netherlands Proteomics Centre

Without the right predictive analytical methods and tools, the cell and gene therapy field will be held back

Boston bioscientists have found an unlikely ally in anthrax toxins, which could form the basis for a new kind of painkiller.

Analytical science can take cell therapy manufacturing to the next level: in-line measurement of critical quality attributes

Access to quality samples is vital for biotech companies – so why aren’t they getting it?

A new cryobioprinting strategy could maximize the shelf life of bioprinted 3D tissue